Ad/Pdtm 2025r John 2025. Below is a summary of some of the important information you might need when attending ad/pd™ 2024 in lisbon. —preliminary data suggest that gene therapy via neurosurgical administration is generally safe, well tolerated and associated with enhanced mean putaminal coverage and.

> ad/pd™ 2025 > participant information. Ad/pd™ 2025 will continue that tradition with sessions of forum discussions, symposia, oral and poster presentations devoted to latest breakthroughs in treatment, translational r&d,.